FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Azacitidine Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Teva Pharmaceuticals (New 10/30/2019)

Company Contact Information:

Presentation Posting Date Related Information
100 mg/1 unit (NDC 0591-2897-49) 10/30/2019 The product has not been marketed for an extended period of time. Teva made a business decision to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English